AZTA

Azenta Inc
NASDAQHEALTHCAREMEDICAL INSTRUMENTS & SUPPLIES

Key Statistics

Market Cap
$1.04B
P/E Ratio
38.95
EPS
$0.58
Beta
1.47
52W High
$41.73
52W Low
$19.87
50-Day MA
$27.07
200-Day MA
$31.03
Dividend Yield
Profit Margin
-10.10%
Forward P/E
30.86
PEG Ratio
0.53

About Azenta Inc

Azenta Inc. is a leading provider of sample management solutions and life science tools, specializing in enhancing laboratory efficiencies for the biotechnology and pharmaceutical sectors. Leveraging innovative automated solutions, biorepository services, and advanced storage technologies, the company empowers clients to accelerate drug discovery while maintaining strict regulatory compliance. With a strong focus on cutting-edge technology and collaborative partnerships, Azenta is strategically positioned to capitalize on growth opportunities within the expanding global life sciences market. Its unwavering commitment to advancing scientific research through sophisticated products further reinforces its competitive edge in biobanking and sample management.

Official WebsiteUSAFY End: September

Fundamentals

Revenue (TTM)$595.03M
Gross Profit (TTM)$265.16M
EBITDA$37.33M
Operating Margin-4.10%
Return on Equity1.53%
Return on Assets-0.59%
Revenue/Share (TTM)$12.99
Book Value$37.26
Price-to-Book0.61
Price-to-Sales (TTM)1.75
EV/Revenue1.155
EV/EBITDA18.44
Quarterly Earnings Growth (YoY)8778.00%
Quarterly Revenue Growth (YoY)0.80%
Shares Outstanding$46.06M
Float$40.65M
% Insiders0.92%
% Institutions116.15%

Analyst Ratings

Consensus ($37.83 target)
2
Strong Buy
2
Buy
3
Hold
Data last updated: 4/7/2026